Chemoinformaics analysis of costic-acid-methyl-ester
| Molecular Weight | 328.32 | nRot | 4 |
| Heavy Atom Molecular Weight | 312.192 | nRig | 18 |
| Exact Molecular Weight | 328.095 | nRing | 3 |
| Solubility: LogS | -4.421 | nHRing | 1 |
| Solubility: LogP | 3.615 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 17 |
| nHA | 6 | APOL | 45.5407 |
| nHD | 1 | BPOL | 23.8633 |
| QED | 0.792 |
| Synth | 2.148 |
| Natural Product Likeliness | 0.863 |
| NR-PPAR-gamma | 0.824 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.933 |
| Pgp-sub | 0.018 |
| HIA | 0.017 |
| CACO-2 | -4.733 |
| MDCK | 0.0000313 |
| BBB | 0.034 |
| PPB | 0.872719 |
| VDSS | 0.785 |
| FU | 0.113115 |
| CYP1A2-inh | 0.957 |
| CYP1A2-sub | 0.966 |
| CYP2c19-inh | 0.794 |
| CYP2c19-sub | 0.295 |
| CYP2c9-inh | 0.726 |
| CYP2c9-sub | 0.925 |
| CYP2d6-inh | 0.481 |
| CYP2d6-sub | 0.939 |
| CYP3a4-inh | 0.799 |
| CYP3a4-sub | 0.346 |
| CL | 6.627 |
| T12 | 0.509 |
| hERG | 0.052 |
| Ames | 0.484 |
| ROA | 0.063 |
| SkinSen | 0.649 |
| Carcinogencity | 0.039 |
| EI | 0.471 |
| Respiratory | 0.58 |
| NR-Aromatase | 0.834 |
| Antiviral | Yes |
| Prediction | 0.861007 |